Contrast media and clotting: What is the evidence?

Catheterization and Cardiovascular Interventions

Volumn 75, Issue SUPPL. 1, 2010, Pages

  Reiner, Jonathan S ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Contrast media (CONT); Percutaneous coronary intervention (PCI); Thrombosis (THRM)

Indexed keywords

ABCIXIMAB; DIATRIZOATE; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; IOTALAMIC ACID; IOVERSOL; IOXAGLIC ACID; MEGLUMINE DIATRIZOATE; MEGLUMINE IOTALAMATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; MEGLUMINE IOXITALAMATE PLUS SODIUM IOXITALAMATE;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; ISCHEMIA; KIDNEY DISEASE; OSMOLALITY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSPECIFIED SIDE EFFECT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD COAGULATION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; EVIDENCE-BASED MEDICINE; HUMANS; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 77950457185     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22406     Document Type: Review

References (20)

1. Katzberg RW, Haller C. Contrast-induced nephrotoxicity: Clinical landscape. Kidney Int Suppl 2006;69:S3-S7.
2. Sharma SK. Iodinated contrast media and contrast-induced nephropathy: Is there a preferred cost-effective agent? J Invasive Cardiol 2008;20:245-248.
3. Schrader R. Contrast media selection in interventional cardiology. Clin Basic Cardiol 2002;4:245-248.
4. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: Analysis of data from reports to the US food and drug administration. Radiology 1997;203:605-610.
5. Robertson HJ. Blood clot formation in angiographic syringes containing nonionic contrast media. Radiology 1987;162:621-622.
6. Riemann CD, Massey CV, McCarron DL, Borkowski P, Johnson PC, Ziskind AA. Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfaces. Am Heart J 1993;125:71-78.
7. Lembo NJ, King SB III, Roubin GS, Black AJ, Douglas JS. Effects of nonionic versus ionic contrast media on complications of percutaneous transluminal coronary angioplasty. Am J Cardiol 1991;67:1046-1050.
8. Esplugas E, Cequier A, Jara F, et al. Risk of thrombosis during coronary angioplasty with low osmolality contrast media. Am J Cardiol 1991;68:1020-1024.
9. Piessens JH, Stammen F, Vrolix MC, et al. Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. Cathet Cardiovasc Diagn 1993;28:99-105.
10. Lefevre T, Bernard A, Bertrand M, et al. Comparison by scanning electron microscopy of the antithrombotic potential of two low osmolality iodine contrast media during percutaneous coronary angioplasty. Arch Mal Coeur 1994;87:225-233.
11. Grines CL, Schreiber TL, Savas V, et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;27:1381-1386.
12. Qureshi NR, den Heijer P, Crijns HJGM. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina. Am J Cardiol 1997;80:700-704.
13. Malekianpour M, Bonan R, Lespérance J, et al. Comparison of ionic and non-ionic low osmolar contrast media in relation to thrombotic complications of angioplasty in patients with unstable angina. Am Heart J 1998;135:1067-1075.
14. Schrader R, Esch I, Ensslen R, et al. A randomized trial comparing the impact of a nonionic (iomeprol) versus an ionic (ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J Am Coll Cardiol 1999;33:395-402.
15. Bertrand ME, Esplugas E, Piessens J, et al. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in percutaneous transluminal coronary angioplasty [VIP] trial investigators. Circulation 2000;101:131-136.
16. Davidson CJ, Laskey WK, Hermiller JB, et al. Randomized trial of contrast media utilization in high-risk PTCA. The COURT trial. Circulation 2000;101:2172-2177.
17. Harrison KJ, Hermiller JB, Vetrovec GW, et al. A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs. iopamidol (Isovue): Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial. Circulation 2003;108 (Supp IV):IV354-IV355.
18. Le Feuvre C, Batisse A, Collet JP, et al. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty. Cathet Cardiovasc Interv 2006;67:852-858.
19. Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 1993;88:2035-2044.
20. Owens MR, Ribes JA, Marder YJ, Francis CW. Effects of ionic and nonionic radiographic contrast agents on endothelial cells in vitro. J Lab Clin Med 1992;119:315-319.